Quick Answer
iBio, Inc. reported Shares Outstanding of 19.35 million shares for fiscal year 2025.
iBio, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 19.35M | +124.4% |
| 2024 | 8.62M | +749.2% |
| 2023 | 1.02M | -88.4% |
| 2022 | 8.73M | +0.1% |
| 2021 | 8.71M | -93.8% |
| 2020 | 140.07M | +595.1% |
| 2019 | 20.15M | +25.6% |
| 2018 | 16.04M | +80.0% |
| 2017 | 8.91M | -90.0% |
| 2017 | 89.12M | +0.0% |
| 2016 | 89.11M | +15.4% |
| 2015 | 77.21M | +17.6% |
| 2014 | 65.64M | +15.8% |
| 2013 | 56.69M | +18.7% |
| 2012 | 47.77M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | 30.05M | +227.8% | +48.4% |
| September 30, 2025 | 20.25M | +134.5% | +4.7% |
| June 30, 2025 | 19.35M | +124.4% | +92.2% |
| March 31, 2025 | 10.07M | +18.2% | +9.8% |
| December 31, 2024 | 9.17M | +182.6% | +6.1% |
| September 30, 2024 | 8.64M | -68.8% | +0.2% |
| June 30, 2024 | 8.62M | +749.2% | +1.2% |
| March 31, 2024 | 8.52M | -31.1% | +162.6% |
- iBio, Inc. showed an increase of +124.4% in Shares Outstanding compared to the prior fiscal year.
- Over the 2012–2025 period, iBio, Inc.’s shares outstanding has declined by 59.5% (from 47.77 million shares to 19.35 million shares).
- The most recent figure is from iBio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 5, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: